수의 감염증 진단 시장 : 세계 예측(2026-2032년)

The Veterinary Infectious Disease Diagnostics Market is projected to grow by USD 4.33 billion at a CAGR of 8.65% by 2032.

Veterinary infectious disease diagnostics are becoming central to animal health, food security, zoonotic disease surveillance, and antimicrobial stewardship. The field covers laboratory and point-of-care tools used to detect bacterial, viral, fungal, and parasitic pathogens in companion animals, livestock, poultry, aquaculture species, and wildlife. Core technologies include PCR and other nucleic acid amplification tests, immunoassays, lateral flow tests, culture and antimicrobial susceptibility testing, sequencing-based methods, serology, and digital pathology support systems. Demand is shaped by well-documented drivers, including rising pet ownership, intensifying livestock production, recurring transboundary animal diseases, increased awareness of zoonoses, and stricter biosecurity expectations across animal protein supply chains. Diagnostic decisions increasingly influence treatment selection, herd management, vaccination strategies, movement controls, and trade compliance. As a result, veterinary infectious disease diagnostics are shifting from reactive confirmation toward earlier detection, syndromic testing, integrated surveillance, and evidence-based disease prevention.

Transformative Shifts in the Veterinary Diagnostics Landscape

The veterinary diagnostics landscape is undergoing a structural shift from centralized, single-pathogen testing toward faster, multiplexed, and connected diagnostic ecosystems. Molecular diagnostics are gaining prominence because they can identify pathogens with high analytical sensitivity, support outbreak confirmation, and differentiate closely related agents when assays are well designed and validated. Point-of-care testing is expanding in clinics, farms, shelters, and field settings, enabling faster triage for diseases such as canine parvovirus, feline leukemia virus, bovine respiratory disease pathogens, avian influenza, and parasitic infections. At the same time, laboratories are adopting automation, sample-to-answer workflows, and quality management systems to improve reproducibility and turnaround time. Another major shift is the alignment of veterinary diagnostics with One Health frameworks, as surveillance for avian influenza, rabies, brucellosis, leptospirosis, salmonellosis, antimicrobial resistance, and vector-borne diseases increasingly requires coordination among veterinary, public health, environmental, and food safety stakeholders. Regulatory expectations for test validation, traceability, and biosurveillance reporting are also influencing procurement decisions and laboratory practices.

Cumulative Impact of Artificial Intelligence on Veterinary Diagnostics

Artificial intelligence is creating cumulative impact across veterinary infectious disease diagnostics by improving image analysis, outbreak intelligence, workflow prioritization, and decision support. In diagnostic imaging and digital microscopy, AI-enabled tools can assist with recognition of parasites, cytology patterns, and lesion-associated features when trained on validated datasets and used under professional oversight. In molecular and sequencing workflows, machine learning can support pathogen classification, variant monitoring, primer design assessment, contamination flagging, and interpretation of complex results. AI is also increasingly relevant for syndromic surveillance, where clinical signs, laboratory results, geospatial signals, weather patterns, animal movement data, and production metrics can be analyzed to identify abnormal disease clusters earlier. However, the practical value of AI depends on transparent validation, representative datasets, cybersecurity controls, interoperability with laboratory information systems, and human-in-the-loop governance. The strongest use cases are not replacing veterinarians or diagnosticians, but reducing time to insight, improving consistency, and helping animal health systems respond more rapidly to infectious disease threats.

Key Regional Insights for Veterinary Infectious Disease Diagnostics

Asia-Pacific is a critical region for veterinary infectious disease diagnostics because of its large livestock populations, major aquaculture activity, dense poultry production, and recurring exposure to transboundary and zoonotic diseases. Diagnostic priorities in the region include avian influenza, African swine fever, foot-and-mouth disease, brucellosis, parasitic infections, and aquatic animal diseases, with increasing emphasis on laboratory capacity, field surveillance, and rapid outbreak confirmation. North America benefits from advanced veterinary laboratory networks, established companion animal care pathways, strong livestock biosecurity programs, and active surveillance for diseases such as rabies, bovine tuberculosis, avian influenza, and antimicrobial resistance. Latin America's diagnostic needs are closely linked to cattle, poultry, swine, and companion animal health, with foot-and-mouth disease control, brucellosis, leptospirosis, tick-borne disease, and export-related sanitary compliance shaping testing priorities. Europe is characterized by strict animal health regulations, cross-border surveillance, high companion animal diagnostic adoption, and coordinated disease monitoring under regional animal health frameworks. The Middle East places emphasis on livestock, equine, camel, and poultry diagnostics, with priorities including zoonotic disease surveillance, import controls, food security, and preparedness for notifiable animal diseases. Africa faces a high burden of endemic and transboundary animal diseases, including peste des petits ruminants, foot-and-mouth disease, trypanosomiasis, rabies, brucellosis, and avian influenza, making accessible field diagnostics, laboratory strengthening, and regional surveillance integration especially important.

Key Group Insights Across Strategic Economic and Policy Blocs

ASEAN's veterinary diagnostic priorities are shaped by intensive poultry and swine production, aquaculture, companion animal growth, and recurring threats such as avian influenza, African swine fever, rabies, and aquatic pathogens. Harmonized surveillance and laboratory quality improvement are increasingly important as intra-regional trade and animal movement expand. GCC countries focus on diagnostics that support food security, imported animal screening, camel and equine health, poultry production, and zoonotic disease monitoring, with laboratory modernization and rapid testing playing key roles in disease preparedness. The European Union maintains one of the most structured animal health environments, with harmonized disease notification, reference laboratory networks, antimicrobial resistance monitoring, and traceability requirements driving consistent diagnostic adoption. BRICS countries collectively represent diverse veterinary diagnostic needs, from large-scale livestock and poultry health management to companion animal testing and national surveillance programs, with growing emphasis on domestic laboratory capacity, molecular diagnostics, and digital reporting. G7 countries generally demonstrate mature diagnostic infrastructure, strong regulatory oversight, high companion animal testing utilization, and advanced surveillance systems for emerging and re-emerging animal diseases. NATO member countries, while primarily defined by security cooperation, often emphasize biosecurity, resilience of food systems, and preparedness for biological threats, reinforcing the strategic relevance of veterinary infectious disease diagnostics in national and cross-border risk management.

Key Country Insights for Veterinary Infectious Disease Diagnostics

The United States has a highly developed veterinary diagnostic ecosystem supported by university, state, private, and federal laboratory networks, with strong activity in companion animal diagnostics, livestock disease surveillance, avian influenza monitoring, and antimicrobial resistance programs. China has expanded veterinary diagnostic capacity in response to African swine fever, avian influenza, livestock intensification, aquaculture health, and growing pet care demand. Germany combines advanced companion animal diagnostics with robust livestock and food animal surveillance, supported by European animal health regulations and strong laboratory quality standards. Japan's diagnostic environment emphasizes high laboratory standards, companion animal care, livestock biosecurity, and preparedness for avian influenza and other notifiable diseases. India's needs are shaped by large cattle, buffalo, poultry, small ruminant, and companion animal populations, with key focus areas including foot-and-mouth disease, brucellosis, rabies, parasitic infections, mastitis pathogens, and antimicrobial stewardship. The United Kingdom maintains strong veterinary laboratory capability and disease surveillance, with attention to bovine tuberculosis, avian influenza, antimicrobial resistance, and companion animal infectious disease testing. Canada emphasizes animal health surveillance across livestock, poultry, wildlife, and companion animals, with diagnostic priorities linked to biosecurity, zoonotic disease control, and trade continuity. Russia's priorities include livestock disease surveillance, transboundary disease preparedness, companion animal testing, and regional laboratory coverage across a large geography. Brazil's extensive cattle, poultry, and swine sectors drive demand for diagnostics related to foot-and-mouth disease surveillance, brucellosis, avian influenza preparedness, parasitic disease, and export compliance. Italy, France, and Spain pair strong companion animal care with livestock and food animal surveillance, supported by European notifiable disease systems, antimicrobial resistance monitoring, and laboratory quality requirements. Mexico's diagnostic landscape is influenced by livestock health, companion animal care, poultry production, rabies control, brucellosis, and cross-border sanitary requirements. Australia benefits from strong biosecurity governance and surveillance capabilities, with diagnostic priorities spanning livestock, wildlife, companion animals, and exotic disease exclusion. South Korea has advanced veterinary diagnostic infrastructure focused on companion animal health, poultry and swine disease monitoring, avian influenza, African swine fever, and national biosecurity readiness.

Actionable Recommendations for Veterinary Diagnostics Leaders

Industry leaders should prioritize validated, fit-for-purpose diagnostic solutions that align with clinical decision-making, surveillance requirements, and field conditions. Investment in multiplex PCR, rapid antigen testing, serology, antimicrobial susceptibility testing, and sequencing should be matched with clear quality assurance, sample logistics, and result interpretation protocols. Diagnostic providers and animal health stakeholders should strengthen interoperability between laboratory information systems, veterinary practice platforms, herd management software, and surveillance databases to accelerate reporting and epidemiological analysis. Organizations should also design products and services for practical deployment, including rugged point-of-care formats, cold-chain-conscious reagents, simplified sample preparation, and multilingual training resources. For AI-enabled diagnostics, leaders should establish validation standards, bias monitoring, data governance, and clinician oversight before broad deployment. Partnerships with veterinary schools, reference laboratories, producer groups, public health agencies, and food safety authorities can improve adoption while supporting One Health outcomes. Finally, market participants should differentiate through scientific credibility, regulatory readiness, technical support, and evidence that diagnostics improve animal welfare, treatment precision, outbreak response, and biosecurity performance.

Research Methodology

This executive summary is developed using a structured secondary research approach grounded in publicly available and verifiable sources, including animal health authority publications, veterinary epidemiology literature, peer-reviewed journals, regulatory guidance, disease surveillance reports, diagnostic validation standards, and recognized One Health resources. The analysis reviews technology adoption trends, regional disease priorities, policy frameworks, laboratory infrastructure, and clinical use cases across companion animals, livestock, poultry, aquaculture, equine health, and wildlife surveillance. Insights are synthesized without market sizing, market share estimation, or forecasting. Emphasis is placed on evidence-backed patterns such as documented disease burdens, surveillance priorities, test modality evolution, regulatory expectations, and practical barriers to diagnostic access. The methodology also applies qualitative triangulation, comparing multiple credible source categories to reduce overreliance on a single viewpoint and to ensure that conclusions reflect real-world veterinary diagnostic practice.

Conclusion

Veterinary infectious disease diagnostics are now a foundational component of animal health systems, supporting early detection, targeted treatment, disease prevention, and cross-sector One Health surveillance. The sector is being reshaped by molecular testing, rapid point-of-care diagnostics, digital connectivity, sequencing, and carefully governed artificial intelligence. Regional needs differ substantially, but common priorities include faster outbreak response, reliable test validation, improved access in field settings, antimicrobial stewardship, and integration of veterinary data into broader health security frameworks. Organizations that combine scientific rigor with practical usability, regulatory alignment, and strong digital infrastructure will be best positioned to support veterinarians, producers, laboratories, and public agencies. As infectious disease risks continue to affect companion animals, livestock, wildlife, and global food systems, diagnostics will remain essential to resilience, biosecurity, and evidence-based animal care.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. New Revenue Opportunities
• 3.5. Next-Generation Business Models
• 3.6. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Veterinary Infectious Disease Diagnostics Market, by Disease Category

• 7.1. Introduction
• 7.2. Bacterial
• 7.3. Fungal
• 7.4. Parasitic
• 7.5. Viral

8. Veterinary Infectious Disease Diagnostics Market, by Product

• 8.1. Introduction
• 8.2. Consumables
  • 8.2.1. Reagents
  • 8.2.2. Test kits
• 8.3. Instruments/Analyzers
  • 8.3.1. Clinical chemistry analyzers
  • 8.3.2. Hematology analyzers
  • 8.3.3. Immunodiagnostic analyzers
  • 8.3.4. Molecular diagnostic analyzers

9. Veterinary Infectious Disease Diagnostics Market, by Offering

• 9.1. Introduction
• 9.2. Hardware
• 9.3. Services
• 9.4. Software

10. Veterinary Infectious Disease Diagnostics Market, by Animal Type

• 10.1. Introduction
• 10.2. Companion Animals
  • 10.2.1. Cat
  • 10.2.2. Dog
• 10.3. Livestock/Production Animals
  • 10.3.1. Cattle
  • 10.3.2. Goats
  • 10.3.3. Poultry
  • 10.3.4. Sheep
  • 10.3.5. Swine

11. Veterinary Infectious Disease Diagnostics Market, by End Use

• 11.1. Introduction
• 11.2. In-House Testing Facilities
  • 11.2.1. Animal Shelters
  • 11.2.2. Pet Owners
• 11.3. Research Laboratories
• 11.4. Veterinary Hospitals & Clinics

12. Veterinary Infectious Disease Diagnostics Market, by Region

• 12.1. Asia-Pacific
• 12.2. North America
• 12.3. Latin America
• 12.4. Europe
• 12.5. Middle East
• 12.6. Africa

13. Veterinary Infectious Disease Diagnostics Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Veterinary Infectious Disease Diagnostics Market, by Country

• 14.1. United States
• 14.2. China
• 14.3. Germany
• 14.4. Japan
• 14.5. India
• 14.6. United Kingdom
• 14.7. Canada
• 14.8. Russia
• 14.9. Brazil
• 14.10. Italy
• 14.11. Mexico
• 14.12. France
• 14.13. Spain
• 14.14. Australia
• 14.15. South Korea

15. Competitive Landscape

• 15.1. Market Share Analysis, 2025
• 15.2. FPNV Positioning Matrix, 2025
• 15.3. Market Concentration Analysis, 2025
  • 15.3.1. Concentration Ratio (CR)
  • 15.3.2. Herfindahl Hirschman Index (HHI)
• 15.4. Recent Developments & Impact Analysis, 2025
• 15.5. Product Portfolio Analysis, 2025
• 15.6. Benchmarking Analysis, 2025

16. Company Profiles

• 16.1. Agrolabo S.p.A.
• 16.2. Antech Diagnostics, Inc.
• 16.3. Bio-Rad Laboratories, Inc.
• 16.4. Biogal Galed Labs
• 16.5. BioMerieux S.A.
• 16.6. BioNote, Inc.
• 16.7. Demeditec Diagnostics GmbH
• 16.8. DEXX Laboratories Inc.
• 16.9. Eurofins Technologies
• 16.10. Fassisi GmbH
• 16.11. FUJIFILM Holdings Corporation
• 16.12. IDEXX Laboratories, Inc.
• 16.13. IDvet
• 16.14. Mars, Incorporated
• 16.15. Merck & Co., Inc.
• 16.16. Neogen Corporation
• 16.17. Nisseiken Co., Ltd
• 16.18. Qiagen N.V.
• 16.19. Randox Laboratories, Ltd.
• 16.20. Shenzhen Bioeasy Biotechnology Co., Ltd.
• 16.21. Shenzhen Mindray Animal Medical Technology Co., Ltd.
• 16.22. SKYER, Inc.
• 16.23. Skyla Corporation
• 16.24. Thermo Fisher Scientific Inc.
• 16.25. Vimian Group AB
• 16.26. Virbac S.A.
• 16.27. Zoetis Inc.